Back
ESC Premium Access

Inhaled iloprost, exercise hemodynamics, and ventricular performance in heart failure with preserved ejection fraction

Session: New treatment studies in heart failure
Topic: Pharmacotherapy
Speaker: Doctor J. Cheng (Taipei, TW)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Jen-Fang Cheng

National Taiwan University Hospital, Taipei (Taiwan)
0 follower

8 more presentations in this session

Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial

Speaker: Doctor D. Fouassier (Paris, FR)

Access
Abstract
Slides
Video
Thumbnail

Drug effect of luseogliflozin and voglibose on heart failure with preserved ejection fraction in diabetic patients: a multicenter randomized-controlled trial

Speaker: Doctor H. Kihara (Asahikawa, JP)

Access
Abstract
Slides
Video
Thumbnail

Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis

Speaker: Associate Professor A. Kalogeropoulos (Stony Brook, US)

Access
Thumbnail

Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction

Speaker: Mr M. Godet (Rouen, FR)

Access
Abstract
Slides
Video
Thumbnail

Clinical predictors of NT-proBNP response to early initiation of sacubitril/valsartan after hospitalisation for decompensated heart failure: An analysis of the TRANSITION study

Speaker: Doctor D. Pascual Figal (Murcia, ES)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

New treatment studies in heart failure

Speakers: Doctor J. Cheng, Doctor D. Fouassier, Doctor H. Kihara, Associate Professor A. Kalogeropoulos, Mr M. Godet...
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb